| An EQ-5D-5L value set based on Uruguayan population preferences F Augustovski, L Rey-Ares, V Irazola, OU Garay, O Gianneo, G Fernández, ... Quality of Life Research 25, 323-333, 2016 | 123 | 2016 |
| Implications of global pricing policies on access to innovative drugs: the case of trastuzumab in seven Latin American countries A Pichon-Riviere, OU Garay, F Augustovski, C Vallejos, L Huayanay, ... International journal of technology assessment in health care 31 (1-2), 2-11, 2015 | 61 | 2015 |
| Eliminating artificial trans fatty acids in Argentina: estimated effects on the burden of coronary heart disease and costs A Rubinstein, N Elorriaga, OU Garay, R Poggio, J Caporale, MG Matta, ... Bulletin of the World Health Organization 93, 614-622, 2015 | 58 | 2015 |
| Cost-effectiveness analysis comparing companion diagnostic tests for EGFR, ALK, and ROS1 versus next-generation sequencing (NGS) in advanced adenocarcinoma lung cancer patients L Schluckebier, R Caetano, OU Garay, GT Montenegro, M Custodio, ... BMC cancer 20, 1-10, 2020 | 46 | 2020 |
| Economic evaluation guidelines in Latin America: a current snapshot F Augustovski, OU Garay, A Pichon-Riviere, A Rubinstein, JE Caporale Expert review of pharmacoeconomics & outcomes research 10 (5), 525-537, 2010 | 39 | 2010 |
| Clozapine-associated neutropenia and agranulocytosis in Argentina (2007–2012) MV Balda, OU Garay, RM Papale, I Bignone, VG Bologna, A Brandolini, ... International Clinical Psychopharmacology 30 (2), 109-114, 2015 | 32 | 2015 |
| El análisis de impacto presupuestario en salud: puesta al día con un modelo de abordaje genérico O Ulises Garay, JE Caporale, A Pichón-Riviere, S García Martí, ... Revista Peruana de Medicina Experimental y Salud Pública 28, 540-547, 2011 | 27 | 2011 |
| Alcohol consumption’s attributable disease burden and cost-effectiveness of targeted public health interventions: a systematic review of mathematical models AE Bardach, AO Alcaraz, A Ciapponi, OU Garay, AP Riviere, A Palacios, ... BMC Public Health 19, 1-15, 2019 | 25 | 2019 |
| The cost-effectiveness of continuous versus intermittent renal replacement therapies in acute kidney injury: perspective of the social services for the elderly in Argentina OU Garay, A Palacios, A Pichon-Riviere, F Augustovski, SG Martí, ... Value in Health Regional Issues 20, 142-148, 2019 | 15 | 2019 |
| Oxytocin in uniject disposable auto-disable injection system versus standard use for the prevention of postpartum hemorrhage in latin America and the Caribbean: a cost … A Pichon-Riviere, D Glujovsky, OU Garay, F Augustovski, A Ciapponi, ... PloS one 10 (6), e0129044, 2015 | 15 | 2015 |
| Budgetary impact analysis in health: update with a model using a generic approach OU Garay, JE Caporale, A Pichón-Riviere, SG Martí, M Mac Mullen, ... Revista Peruana de Medicina Experimental y Salud Publica 28 (3), 540-547, 2011 | 13 | 2011 |
| Health economic evaluation of Human Papillomavirus vaccines in women from Venezuela by a lifetime Markov cohort model AE Bardach, OU Garay, M Calderón, A Pichón-Riviére, F Augustovski, ... BMC Public Health 17, 1-15, 2017 | 12 | 2017 |
| Single-use devices in Argentina: cost comparison analysis of a “re-use” versus a “single-use” policy for trocars, endocutters, linear cutters, and harmonic scalpels OU Garay, EG Elorrio, V Rodríguez, C Spira, F Augustovski, ... Value in Health Regional Issues 14, 89-95, 2017 | 11 | 2017 |
| Evaluación del impacto sanitario del Programa Estaciones Saludables en la Ciudad Autónoma de Buenos Aires, Argentina N Elorriaga, OU Garay, M Belizán, VB González, ML Rossi, M Chaparro, ... Revista Panamericana de Salud Pública 42, e150, 2018 | 8 | 2018 |
| HT3 BASE DE COSTOS UNITARIOS EN SALUD EN ARGENTINA: UNA FUENTE DE INFORMACIÓN CONTINUAMENTE ACTUALIZADA PARA EVALUACIONES ECONOMICAS Y ANALISIS DE IMPACTO PRESUPUESTARIO EN UN … A Palacios, D Balan, OU Garay, M Mena, A Souto, F Augustovski, ... Value in Health Regional Issues 19, S8, 2019 | 7 | 2019 |
| Carboplatin plus pemetrexed offers superior cost-effectiveness compared to pemetrexed in patients with advanced non-small cell lung cancer and performance status 2 L Schluckebier, OU Garay, M Zukin, CG Ferreira Lung Cancer 89 (3), 274-279, 2015 | 6 | 2015 |
| Impacto de la obesidad en pacientes con neumonía grave por virus influenza A/H1N1: estudio multicéntrico chileno F Arancibia, S Ugarte, R Soto, A Hernández, R Alonzo, G Pérez, ... Rev. chil. med. intensiv, 7-16, 2011 | 5 | 2011 |
| Budget impact analysis of using procalcitonin to optimize antimicrobial treatment for patients with suspected sepsis in the intensive care unit and hospitalized lower … OU Garay, G Guiñazú, W Cornistein, J Farina, R Valentini, G Levy Hara Plos one 16 (4), e0250711, 2021 | 4 | 2021 |
| Medical devices: from licensing to coverage. highlights from Argentina, Brazil, Colombia and Mexico L Rey-Ares, A Hernández-Vásquez, OU Garay, A Pichon Riviere, ... Expert review of medical devices 13 (11), 1053-1065, 2016 | 4 | 2016 |
| CN1 Cost-effectiveness of trastuzumab in the adjuvant treatment of early breast cancer in six Latin American countries A Pichón-Rivière, F Augustovski, OU Garay, J Buendia, A Rodríguez, ... Value in Health 14 (7), A538, 2011 | 4 | 2011 |
